An encapsulated breast implant is one that has become surrounded by a tight, thickened layer of scar tissue that squeezes the implant and changes how the breast looks or feels. Every breast implant triggers some scar tissue formation, and that’s normal. The body naturally builds a thin collagen capsule around any foreign object within minutes of surgery. The problem starts when that capsule thickens, hardens, and contracts, a condition called capsular contracture. It affects roughly 15% to 45% of breast augmentation patients, with the vast majority of cases developing within the first year.
Why the Body Builds a Capsule
Your immune system treats a breast implant the way it treats any foreign material: it walls it off. This process begins almost immediately after surgery and moves through several stages of inflammation, starting with blood interacting with the implant surface, then progressing through acute and chronic inflammation, and finally settling into a stable fibrous capsule. Under normal circumstances, that capsule stays thin, flexible, and completely harmless. You won’t feel it or know it’s there.
The trouble begins when something keeps the inflammation going longer than it should. Persistent inflammation causes certain immune cells to stay in an aggressive, scar-producing mode instead of switching to a calmer repair mode. Over time, the capsule thickens with dense fibrous tissue, stiffens, and begins to squeeze inward on the implant. That squeeze is what distorts the breast shape and causes pain.
What Triggers Problematic Encapsulation
Several factors can push a normal capsule toward contracture:
- Bacterial biofilm: A microscopic layer of bacteria on the implant surface can sustain low-grade inflammation indefinitely, even without causing an obvious infection.
- Silicone particle shedding: Small amounts of silicone can leak from the implant shell over time, irritating surrounding tissue.
- Chronic micromotion: Repeated small movements of the implant within the pocket can keep the inflammatory cycle active.
- Bleeding or fluid collection: Blood (hematoma) or fluid (seroma) around the implant in the early postoperative period provides a medium for bacteria and prolongs inflammation.
Implant placement also matters. Implants placed above the chest muscle (subglandular) carry a higher risk of contracture than those placed beneath it (submuscular). A meta-analysis found that submuscular placement significantly reduces both contracture risk and overall implant failure rates.
The Four Grades of Contracture
Doctors classify encapsulation severity using the Baker scale, a four-point grading system based on how the breast looks and feels:
- Grade I: The breast feels soft and looks normal. The capsule is thin and supple. This is what a healthy, expected capsule looks like, and it requires no treatment.
- Grade II: The breast feels slightly firm but still looks normal. Most people at this stage notice a subtle change in texture but aren’t bothered by it.
- Grade III: The breast is noticeably firm and looks visibly abnormal. The implant may appear shifted, rounded in an unnatural way, or distorted.
- Grade IV: The breast is hard, painful, and visibly distorted. Research comparing tissue samples from Grade IV capsules to Grade I capsules found them to be significantly thicker, with a much higher density of cells, and containing more silicone material within the tissue itself.
Grades I and II are generally considered clinically insignificant. Grades III and IV are the ones that typically require intervention.
Symptoms to Recognize
Encapsulation doesn’t always announce itself dramatically. Early signs can be subtle: a feeling of tightness in one breast, a slight change in shape, or the sense that one side feels firmer than the other when you press on it. As contracture progresses, the symptoms become harder to ignore.
Common signs include increasing firmness or hardness in the breast, visible changes in shape or symmetry, pain or tenderness in the breast or nipple area, the ability to feel the edges of the implant through the skin, and hard lumps caused by calcium deposits forming within the thickened capsule. In some cases, especially with silicone gel implants, a rupture can occur inside the contracted capsule without obvious external signs, a situation known as a silent rupture. You might notice a gradual change in breast size or shape, swelling, or new lumps over the chest area.
How Implant Type Affects Risk
The surface texture of the implant plays a measurable role in contracture rates. A large meta-analysis covering over 17,000 cases found that smooth-surfaced implants had nearly three times the rate of capsular contracture compared to textured-surfaced implants. Textured surfaces are thought to disrupt the organized layering of scar tissue that leads to contraction.
That said, textured implants carry their own concerns, including a rare association with a type of lymphoma called BIA-ALCL, which has led some surgeons and patients to prefer smooth implants despite the higher contracture risk. The choice between implant types involves weighing these different risks, and it’s one of the key decisions made before surgery.
Prevention During and After Surgery
Surgeons use a combination of techniques to minimize contracture risk. Placing the implant beneath the chest muscle rather than above it is one of the most well-supported strategies. Irrigating the implant pocket with a triple antibiotic solution or hypochlorous acid helps reduce bacterial contamination. Using a no-touch insertion device (such as a Keller Funnel) minimizes the implant’s contact with skin bacteria during placement.
After surgery, some surgeons prescribe a short course of medication that blocks inflammatory signaling molecules called leukotrienes. In a study of over 1,100 patients, those who took zafirlukast for three months after surgery had a contracture rate of about 2.2%, compared to 5% in untreated patients, cutting the risk by more than half. Montelukast showed a similar trend but with less dramatic results. These medications are typically used off-label, meaning they’re approved for other conditions (like asthma) but applied here based on clinical evidence of benefit.
Treatment Options for Established Contracture
For mild cases (Grade II), some doctors will try a course of leukotriene-blocking medication to soften the capsule and halt progression. Massage techniques may also be recommended, though evidence for their effectiveness varies.
For Grade III and IV contracture, surgery is usually the most reliable option. The two main surgical approaches are capsulotomy, where the surgeon cuts into the capsule to release the tightness, and capsulectomy, where the entire capsule is removed along with the implant. In many cases, the implant is replaced at the same time, often in a different position (such as moving from above the muscle to below it) to reduce the chance of recurrence. Contracture can return after surgical correction, particularly if the underlying triggers like biofilm aren’t fully addressed during the revision.
Some patients with severe or recurring contracture choose to have their implants removed entirely without replacement, especially if they’ve experienced multiple episodes or develop systemic symptoms like fatigue, joint pain, or cognitive changes that some patients associate with their implants.